Recurrent and self-healing cutaneous monoclonal plasmablastic infiltrates in a patient with AIDS and Kaposi sarcoma

British Journal of Dermatology

Volumn 153, Issue 4, 2005, Pages 828-832

  Gilaberte, M ^a   Gallardo, F ^a   Bellosillo, B ^a   Saballs, P ^a   Barranco, C ^a   Serrano, S ^a   Pujol, Ramon M ^a  

^a HOSPITAL DEL MAR   (Spain)

Author keywords

AIDS; Epstein Barr virus; Human herpesvirus 8; Kaposi sarcoma; Plasmablastic lymphoma

Indexed keywords

DIDANOSINE; DOXORUBICIN; NEVIRAPINE; STAVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; EPSTEIN BARR VIRUS; FAT NECROSIS; FOLLOW UP; HEALING; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPATHOLOGY; HUMAN; HUMAN HERPESVIRUS 8; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KAPOSI SARCOMA; LYMPH NODE BIOPSY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECURRENT DISEASE; SKIN BIOPSY; SKIN INFILTRATE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 8, HUMAN; HUMANS; LYMPHOMA, AIDS-RELATED; LYMPHOMA, LARGE-CELL, DIFFUSE; MALE; NEOPLASM REGRESSION, SPONTANEOUS; RECURRENCE; SARCOMA, KAPOSI;

EID: 26244466407     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2005.06803.x     Document Type: Article

References (32)

1. Chetty R, Hlatswayo N, Mue R et al. Plasmablastic lymphoma in HIV+ patients: an expanding spectrum. Histopathology 2003; 42:605-9.
2. Carbone A, Gaidano G, Gloghini A et al. AIDS-related plasmablastic lymphomas of the oral cavity and jaws: a diagnostic dilemma. Ann Otol Rhinol Laryngol 1999; 108:95-9.
3. Schichman SA, McClure R, Schaefer RF, Mehta P. HIV and plasmablastic lymphoma manifesting in sinus, testicles, and bones: a further expansion of the disease spectrum. Am J Hematol 2004; 77:291-5.
4. Lin F, Zhang K, Quiery AT Jr et al. Plasmablastic lymphoma of the cervical lymph nodes in a human immunodeficiency virus-negative patient: a case report and review of the literature. Arch Pathol Lab Med 2004; 128:581-4.
5. van Dongen JJ, Langerak AW, Bruggemann M et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 2003; 17:2257-317.
6. Beylot-Barry M, Vergier B, Masquelier B et al. The spectrum of cutaneous lymphomas in HIV infection: a study of 21 cases. Am J Surg Pathol 1999; 23:1208-12.
7. Mate JL, Navarro JT, Ariza A et al. Oral solid form of primary effusion lymphoma mimicking plasmablastic lymphoma. Hum Pathol 2004; 35:632-5.
8. Thorley-Lawson DA, Gross A. Mechanisms of disease: persistence of the Epstein-Barr virus and the origins of associated lymphomas. N Engl J Med 2004; 350:1328-37.
9. Cohen JI. Benign and malignant Epstein-Barr virus-associated B-cell lymphoproliferative diseases. Semin Hematol 2003; 40:116-23.
10. Yachie A, Kanegane H, Kasahara Y. Epstein-Barr virus-associated TVnatural killer cell lymphoproliferative disease. Semin Hematol 2003; 40:124-32.
11. Malnati MS, Dagna L, Ponzoni M, Lusso P. Human herpesvirus 8 (HHV-8/KSHV) and hematologic malignancies. Rev Clin Exp Hematol 2003; 7:375-405.
12. Aoki Y, Tosato G. Pathogenesis and manifestations of human herpesvirus-8-associated disorders. Semin Hematol 2003; 40:143-53.
13. Dupin N, Diss TL, Kellam P et al. HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. Blood 2000; 95:1406-12.
14. Jenner RG, Maillard K, Cattini N et al. Kaposi's sarcoma-associated herpesvirus-infected primary effusion lymphoma has a plasma cell gene expression profile. Proc Natl Acad Ssi USA 2003; 100:10399-404.
15. Nguyen DD, Loo BW Jr, Tillman G et al. Plasmablastic lymphoma presenting in a human immunodeficiency virus-negative patient: a case report. Ann Hematol 2003; 82:521-5.
16. Du MQ, Diss TC, Liu H et al. KSHV- and EBV-associated germinotropic lymphoproliferative disorder. Blood 2002; 100:3415-18.
17. Matsushima AY, Strauchen JA, Lee G et al. Posttransplantation plasmacytic proliferations related to Kaposi's sarcoma-associated herpesvirus. Am J Surg Pathol 1999; 23:1393-400.
18. Delecluse HJ, Anagnostopoulos I, Dallenbach F et al. Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection. Blood 1997; 89:1413-20.
19. Colomo L, Loong F, Rives S et al. Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities. Am J Surg Pathol 2004; 28:736-47.
20. Carbone A, Gloghini A, Gaidano G. Is plasmablastic lymphoma of the oral cavity an HHV-8-associated disease? Am J Surg Pathol 2004; 28:1251-2.
21. Cioc AM, Allen C, Kalmar JR et al. Oral plasmablastic lymphomas in AIDS patients are associated with human herpesvirus 8. Am J Surg Pathol 2004; 28:41-6.
22. Hausermann P, Khanna N, Buess M et al. Cutaneous plasmablastic lymphoma in an HIV-positive male: an unrecognized cutaneous manifestation. Dermatology 2004; 208:287-90.
23. Nicol I, Boye T, Carsuzaa F et al. Post-transplant plasmablastic lymphoma of the skin. Br J Dermatol 2003; 149:889-91.
24. Lester R, Li C, Galbraith P et al. Improved outcome of human immunodeficiency virus-associated plasmablastic lymphoma of the oral cavity in the era of highly active antiretroviral therapy: a report of two cases. Leuk Lymphoma 2004; 45:1881-5.
25. Nasta SD, Carrum GM, Shahab I et al. Regression of a plasmablastic lymphoma in a patient with HIV on highly active antiretroviral therapy. Leuk Lymphoma 2002; 43:423-6.
26. Berryman R. Primary effusion lymphoma (PEL)-complete remission with HAART (case report). Blood 2000; 96: Abstract 4741.
27. Hoffmann C, Tabrizian S, Wolf E et al. Survival of AIDS patients with primary central nervous system lymphoma is dramatically improved by HAART-induced immune recovery. AIDS 2001; 15:2119-27.
28. Fatkenheuer G, Hell K, Roers A et al. Spontaneous regression of HIV associated T-cell non-Hodgkin's lymphoma with highly active antiretroviral therapy. Eur J Med Res 2000; 5:236-40.
29. Schneider U, Ruhnke M, Delecluse HJ et al. Regression of Epstein-Barr virus-associated lymphoproliferative disorders in patients with acquired immunodeficiency syndrome during therapy with foscarnet. Ann Hematol 2000; 79:214-16.
30. Sarkodee-Adoo C, Pittarelli L, Jaffe E et al. Regression and clonally distinct recurrence of human immunodeficiency virus related Burkitt-like lymphoma during antiretroviral therapy. Leuk Lymphoma 2001: 42:1125-31.
31. Hoffmann C, Chow KU, Wolf E et al. Strong impact of highly active antiretroviral therapy on survival in patients with human immunodeficiency virus-associated Hodgkin's disease. Br J Haematol 2004; 125:455-62.
32. Parekh S, Koduri PR. Spontaneous regression of HIV-associated Hodgkin's disease. Am J Hematol 2003; 72:153-4.